Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
558 studies found for:    "Uveal diseases"
Show Display Options
Rank Status Study
1 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
2 Not yet recruiting Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Conditions: Uveal Melanoma;   Hepatic Metastases
Interventions: Device: SIR-Spheres® Yttrium 90;   Drug: ipilimumab;   Drug: nivolumab
3 Recruiting Ustekinumab (STELARA ) for the Treatment of Active Sight-Threatening Uveitis
Condition: Uveitis
Intervention: Drug: Ustekinumab
4 Not yet recruiting Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography
Condition: Uveitis
Interventions: Device: Optical Coherence Tomography (OCT);   Other: Eye Exam
5 Not yet recruiting Variations in Retinal Nerve Fiber Layer Thickness During Uncomplicated Anterior and Intermediate Uveitis
Conditions: Anterior Uveitis;   Intermediate Uveitis
Intervention:
6 Recruiting Phase II Evaluating Endoresection of the Tumor Scar or Transpupillary Thermotherapy When Endoresection is Not Feasible After Proton Beam Therapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser)
Conditions: Uveal Melanoma;   Melanoma, Uveal
Interventions: Procedure: Endoresection;   Procedure: Laser diode
7 Recruiting Genetic Factors of Idiopathic Polypoidal Vasculopathies in the ATM Gene (Ataxia Telangiectasia Mutated)
Condition: Choroidal Neovascularization
Intervention:
8 Recruiting Intravitreal Conbercept for Idiopathic Choroidal Neovascularization
Condition: Idiopathic Choroidal Neovascularization
Intervention: Drug: conbercept
9 Recruiting Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0)
Condition: Uveal Melanoma
Intervention: Biological: Blood sampling
10 Completed Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
Condition: Subjects Clinically Suspected an Active Source of Toxoplasmosis Chorioretinitis Infection
Interventions: Other: Fluorescein angiography;   Other: Dilated fundus examination;   Biological: Toxoplasmosis serology;   Drug: Anti-toxoplasmosis treatment;   Drug: Anti-inflammatory treatments;   Other: Puncture in anterior chamber
11 Recruiting Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Condition: Uveal Melanoma
Interventions: Drug: Adjuvant chemotherapy by Fotemustin;   Other: Intensive surveillance
12 Recruiting Advanced OCT and Adaptive Optics Imaging in Retinal Disease (The ACAD Study)
Conditions: Vitreous Diseases;   Retinal Diseases;   Choroidal Diseases
Intervention: Device: Swept-source optical coherence tomography (SS-OCT)
13 Recruiting Prospective Observational Study to Assess Effectiveness of Intravitreal Aflibercept in Patients With Wet Macular Degeneration in Greece
Conditions: Choroidal Neovascularization;   Macular Degeneration
Intervention: Drug: VEGF-Trap-Eye (BAY86-5321)
14 Recruiting Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs
Condition: Uveitis
Intervention: Other: Blood sampling
15 Recruiting Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma
Conditions: Uveal Melanoma;   Choroid Neoplasm
Intervention: Biological: ICON-1
16 Not yet recruiting Open Label Study of Acthar SQ Gel Injection in Patients With Active Anterior Uveitis
Condition: Uveitis
Intervention: Drug: Acthar
17 Not yet recruiting Intermittent Selumetinib for Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: Selumetinib
18 Recruiting Aqueous Humor Dynamics and Uveitic Glaucoma
Conditions: Uveitic Glaucoma;   Anterior Uveitis
Intervention:
19 Active, not recruiting Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients
Conditions: Uveitis;   Anterior Uveitis;   Intermediate Uveitis;   Posterior Uveitis;   Scleritis;   Clinically Significant Macular Edema
Intervention: Drug: H.P. ACTHAR SUBCUTANEOUS GEL INJECTION
20 Recruiting 1 Year Canakinumab Treatment in Behcet's Disease Patients With Neurologic or Vascular Involvement
Condition: Behcet Disease
Intervention: Drug: drug administration

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years